Stocks
Zynerba Pharmaceuticals (ZYNE) EBITDA US GAAP (year values) |
|||||||||
| 2018 | 2019 | 2020 | 2021 | 2022 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -40.4 | -34.2 | -52.1 | -36.2 | -34.6 | -38.5 | ||
| Changes by years, y/y, % | +27% | -15% | +52% | -30% | -4% | +1.6% | |||
Zynerba Pharmaceuticals. EBITDA US GAAP, bln rub
Zynerba Pharmaceuticals. EBITDA US GAAP, changes, %
Zynerba Pharmaceuticals. EBITDA US GAAP, sum by quarters, bln rub
Zynerba Pharmaceuticals (ZYNE) EBITDA US GAAP (quarter values) |
||||||||
| 2022Q2 | 2022Q3 | 2022Q4 | 2023Q1 | 2023Q2 | LTM ? | |||
| EBITDA, bln rub | ? | -9.17 | -8.01 | -8.85 | -10.5 | -11.1 | -38.5 | |
| Changes by years, y/y, % | -5% | -24% | +1% | +14% | +21% | |||
| Changes by quarters, q/q, % | +0% | -13% | +11% | +18% | +6% | |||
